What are the ingredient drugs in Technivie?
Medically reviewed by Drugs.com Last updated on May 6, 2019.
Official Answer
by Drugs.comThe ingredient drugs in Technivie are ombitasvir, paritaprevir, and ritonavir which are are antiviral medicines that prevent hepatitis C virus (HCV) from multiplying in your body.
Technivie can be used to treat genotype 4 HCV infections without requiring the need for interferon.
Technivie (ombitasvir, paritaprevir and ritonavir) is an NS5A inhibitor, NS3/4A protease inhibitor, and CYP3A inhibitor fixed-dose combination indicated for use in combination with ribavirin for the treatment of patients with genotype 4 chronic hepatitis C virus (HCV) infection.
In May 2018, the FDA announced that Technivie was to be discontinued. The discontinuation was voluntary and not related to the safety, quality, or efficacy of the medicine. It was estimated that Technivie would be available until January 1, 2019.
